Tahereh Taheri

Tahereh Taheri

UNVERIFIED PROFILE

Are you Tahereh Taheri?   Register this Author

Register author
Tahereh Taheri

Tahereh Taheri

Publications by authors named "Tahereh Taheri"

Are you Tahereh Taheri?   Register this Author

32Publications

543Reads

19Profile Views

A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB/c mice model.

Mol Immunol 2019 07 1;111:152-161. Epub 2019 May 1.

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2019.04.009DOI Listing
July 2019

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.

PLoS Negl Trop Dis 2018 08 22;12(8):e0006701. Epub 2018 Aug 22.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006701DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122837PMC
August 2018

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.

PLoS Negl Trop Dis 2017 12 18;11(12):e0006123. Epub 2017 Dec 18.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749894PMC
December 2017

Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.

Immunotherapy 2017 10;9(13):1089-1102

Department of Immunotherapy & Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran, 13194.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0076DOI Listing
October 2017

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.

PLoS Negl Trop Dis 2017 Jul 14;11(7):e0005774. Epub 2017 Jul 14.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0005774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529023PMC
July 2017

PUF Proteins: Cellular Functions and Potential Applications.

Curr Protein Pept Sci 2017 ;18(3):250-261

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389203717666160914172908DOI Listing
May 2017

Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Infected Macrophage Cells.

Iran J Parasitol 2016 Jul-Sep;11(3):325-331

Dept. of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256048PMC
January 2017

DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening.

Methods Mol Biol 2016 ;1403:603-22

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3387-7_34DOI Listing
December 2016

Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica.

AAPS PharmSciTech 2016 Oct 9;17(5):1110-9. Epub 2015 Nov 9.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1208/s12249-015-0439-1
Publisher Site
http://dx.doi.org/10.1208/s12249-015-0439-1DOI Listing
October 2016

Leishmania-based expression systems.

Appl Microbiol Biotechnol 2016 Sep 20;100(17):7377-85. Epub 2016 Jul 20.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Pasteur Ave. No. 69, Tehran, 13164, Iran.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00253-016-7712-4
Publisher Site
http://dx.doi.org/10.1007/s00253-016-7712-4DOI Listing
September 2016

Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.

Appl Microbiol Biotechnol 2016 Aug 10;100(16):7051-60. Epub 2016 Mar 10.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-016-7422-yDOI Listing
August 2016

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.

Appl Microbiol Biotechnol 2016 May 19;100(9):3923-34. Epub 2015 Dec 19.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-015-7201-1DOI Listing
May 2016

Post-Genomics and Vaccine Improvement for Leishmania.

Front Microbiol 2016 6;7:467. Epub 2016 Apr 6.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2016.00467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822237PMC
April 2016

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy.

J Breast Cancer 2016 Mar 25;19(1):34-44. Epub 2016 Mar 25.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2016.19.1.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822105PMC
March 2016

Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity.

Exp Parasitol 2015 Mar 28;150:44-55. Epub 2015 Jan 28.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00144894150001
Publisher Site
http://dx.doi.org/10.1016/j.exppara.2015.01.008DOI Listing
March 2015

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.

Arch Virol 2015 Jan 28;160(1):141-52. Epub 2014 Oct 28.

Department of Virology, School of Public Health, Tehran University of Medical Sciences, P.O.Box 6446, Tehran, 14155, Islamic Republic of Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00705-014-2243-8DOI Listing
January 2015

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

Immunotherapy 2012 Nov;4(11):1107-20

Molecular Immunology & Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.12.110DOI Listing
November 2012

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.

Parasitol Res 2011 Sep 26;109(3):793-9. Epub 2011 Mar 26.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00436-011-2325-4DOI Listing
September 2011

Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity.

Exp Parasitol 2010 Oct 22;126(2):135-45. Epub 2010 Apr 22.

Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2010.04.009DOI Listing
October 2010

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

Vaccine 2009 Dec 8;28(1):53-62. Epub 2009 Oct 8.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2009.09.114DOI Listing
December 2009

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.

Exp Parasitol 2008 Mar 13;118(3):393-401. Epub 2007 Oct 13.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2007.10.004DOI Listing
March 2008